angiotensin ii has been researched along with Graft-Versus-Host Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batsis, I; Bousiou, Z; Chondropoulos, S; Gavriilaki, E; Gkirkas, K; Griniezaki, M; Karagiannidou, A; Konstantellos, I; Kroupis, C; Lazana, I; Sakellari, I; Stamouli, M; Tsirigotis, P; Vardi, A; Vythoulkas, D | 1 |
| Sheppard, D; Tsujino, K | 1 |
1 review(s) available for angiotensin ii and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Critical Appraisal of the Utility and Limitations of Animal Models of Scleroderma.
Topics: Angiotensin II; Animals; Bleomycin; Disease Models, Animal; Genetic Predisposition to Disease; Graft vs Host Disease; Mice; Mice, Transgenic; Reactive Oxygen Species; Scleroderma, Systemic | 2016 |
1 other study(ies) available for angiotensin ii and Graft-Versus-Host Disease
| Article | Year |
|---|---|
Endothelial Injury Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation: Angiopetin-2 as a Novel Predictor of the Outcome and the Role of Functional Autoantibodies against Angiotensin II Type 1 and Endothelin A Receptor.
Topics: Angiotensin II; Autoantibodies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Peptide Hormones; Receptor, Angiotensin, Type 1; Receptor, Endothelin A | 2023 |